COR

Cencora, Inc. Stock Price

NYSE:COR Community·US$61.5b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 37 Fair Values set on narratives written by author

COR Share Price Performance

US$317.93
84.81 (36.38%)
4.6% undervalued intrinsic discount
US$333.29
Fair Value
US$317.93
84.81 (36.38%)
4.6% undervalued intrinsic discount
US$333.29
Fair Value
Price US$317.93
AnalystConsensusTarget US$333.29

COR Community Narratives

AnalystConsensusTarget·
Fair Value US$333.29 4.6% undervalued intrinsic discount

Digital Infrastructure And Specialty Services Will Redefine Healthcare Delivery

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative

Recent COR News & Updates

Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 09
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Aug 08

Cencora, Inc. Key Details

US$316.7b

Revenue

US$305.9b

Cost of Revenue

US$10.8b

Gross Profit

US$8.9b

Other Expenses

US$1.9b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 05, 2025
Earnings per share (EPS)
9.79
Gross Margin
3.40%
Net Profit Margin
0.60%
Debt/Equity Ratio
372.9%

Cencora, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

2 Risks
3 Rewards

About COR

Founded
1871
Employees
44000
CEO
Robert Mauch
WebsiteView website
www.cencora.com

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: -1.1%
  • 3 Months: 6.8%
  • 1 Year: 15.5%
  • Year to Date: 13.8%
Over the last 7 days, the market has dropped 1.1%, driven by a decline of 1.8% in the Information Technology sector. In the last year, the market is actually up 16%. Looking forward, earnings are forecast to grow by 16% annually. Market details ›